47
Participants
Start Date
September 23, 2021
Primary Completion Date
July 12, 2022
Study Completion Date
July 12, 2022
Sulpiride 400 MG
All participants will receive one single dose of 400mg sulpiride. None of the participants will receive repeated doses. In order for the fMRI data acquisition to coincide with the time-window of maximal drug effects represented by a combination of plasma kinetics and physiological effects we will administer the drug 90 minutes prior to fMRI data acquisition.
Placebo
All participants will receive placebo during one of the sessions.
Donders Centre for Cognition, Radboud University, Nijmegen
Prof. Dr. Robbert-Jan Verkes, Radboud University Medical Centre Department of Psychiatry
UNKNOWN
Funding: NWO + KNAW
UNKNOWN
Donders Centre for Cognitive Neuroimaging
OTHER